Browse All

Current Filters

CLEAR FILTER x

TITLE

Ublituximab, a Novel, Glycoengineered Anti-CD20 Monoclonal Antibody (mAb), Demonstrates Enhanced Antibody-Dependent Cellular Cytotoxicity (ADCC) Relative to Other Anti-CD20 mAbs

Author:Huang, Deren   Alvarez, Enrique   Miskin, Hari   Lee, Lily   Foley, John   

Session Name:P7: MS Therapeutics 1  

Topic:MS and Inflammatory Disease  

Program Number:P7.011  

Author Institution:Mount Carmel Neurology, Powell, OH  University of Colorado, Aurora, CO  TG Therapeutics, New York, NY  Rocky Mountain MS Clinic, Salt Lake City, UT